BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3072363)

  • 1. [Prognostic study of malignant melanoma of the uvea treated by enucleation].
    Bacin F; Kantelip B; Albuisson E; Bonhomme R
    J Fr Ophtalmol; 1988; 11(10):639-49. PubMed ID: 3072363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors for survival after enucleation for choroidal and ciliary body melanomas.
    Isager P; Ehlers N; Overgaard J
    Acta Ophthalmol Scand; 2004 Oct; 82(5):517-25. PubMed ID: 15453846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intratumoral blood pools and prognosis of malignant uveal melanoma treated with enucleation].
    Kantelip B; Albuisson E; Bacin F; Bonhomme R
    Ophtalmologie; 1989; 3(1):49-52. PubMed ID: 2641072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No differences in outcome between radical surgical treatment (enucleation) and stereotactic radiosurgery in patients with posterior uveal melanoma.
    Furdova A; Slezak P; Chorvath M; Waczulikova I; Sramka M; Kralik G
    Neoplasma; 2010; 57(4):377-81. PubMed ID: 20429631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Routes of extraocular extension of uveal melanoma: risk factors and influence on survival probability.
    Coupland SE; Campbell I; Damato B
    Ophthalmology; 2008 Oct; 115(10):1778-85. PubMed ID: 18554722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diffuse malignant melanoma of the uvea. A clinico-histopathologic study of 39 patients].
    Braun UC; Rummelt VC; Naumann GO
    Klin Monbl Augenheilkd; 1998 Dec; 213(6):331-40. PubMed ID: 10048010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas.
    Puusaari I; Heikkonen J; Summanen P; Tarkkanen A; Kivelä T
    Ophthalmology; 2003 Nov; 110(11):2223-34. PubMed ID: 14597534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Retrospective study of uveal melanoma].
    Tóth J
    Magy Onkol; 2005; 49(1):19-25. PubMed ID: 15902329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The follow up of prognostic important factors and analysis of five years survival rate in patients with uveal melanoma at the Department of Ophthalmology, 3rd Medical Faculty Charles University in Prague and the Faculty Hospital Královské Vinohrady in Prague].
    Redinová MV; Sach J; Baráková D; Kuchynka P; Vránová J
    Cesk Slov Oftalmol; 2009 Jan; 65(1):29-35. PubMed ID: 19366035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival after proton-beam irradiation of uveal melanomas.
    Kodjikian L; Roy P; Rouberol F; Garweg JG; Chauvel P; Manon L; Jean-Louis B; Little RE; Sasco AJ; Grange JD
    Am J Ophthalmol; 2004 Jun; 137(6):1002-10. PubMed ID: 15183783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ruthenium brachytherapy for uveal melanoma, 1979-2003: survival and functional outcomes in the Swedish population.
    Bergman L; Nilsson B; Lundell G; Lundell M; Seregard S
    Ophthalmology; 2005 May; 112(5):834-40. PubMed ID: 15878063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posterior uveal melanoma treated with I-125 brachytherapy or primary enucleation.
    Krohn J; Monge OR; Skorpen TN; Mørk SJ; Dahl O
    Eye (Lond); 2008 Nov; 22(11):1398-403. PubMed ID: 17585309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ruthenium-106 plaque brachytherapy for thick posterior uveal melanomas.
    Kaiserman N; Kaiserman I; Hendler K; Frenkel S; Pe'er J
    Br J Ophthalmol; 2009 Sep; 93(9):1167-71. PubMed ID: 19570767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PC-10 as a predictor of prognosis after antigen retrieval in posterior uveal melanoma.
    Seregard S; Oskarsson M; Spångberg B
    Invest Ophthalmol Vis Sci; 1996 Jun; 37(7):1451-8. PubMed ID: 8641848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton beam radiotherapy for uveal melanomas at nice teaching hospital: 16 years' experience.
    Caujolle JP; Mammar H; Chamorey E; Pinon F; Herault J; Gastaud P
    Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):98-103. PubMed ID: 19910136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients.
    Shields CL
    Trans Am Ophthalmol Soc; 2000; 98():471-92. PubMed ID: 11190037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic factors of choroidal melanoma: an anatomo-clinical retrospective and statistical study of 76 enucleated cases].
    Panigel K; Hedelin G; Speeg-Schatz C; Sahel J; Brini A
    J Fr Ophtalmol; 1992; 15(6-7):410-4. PubMed ID: 1294598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Observation or enucleation--a still unsolved problem in patients with uveal melanoma].
    Omulecki W; Swietliczko I
    Klin Oczna; 1991; 93(2-3):73-5. PubMed ID: 1870300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton beam radiotherapy for uveal melanoma: results of Curie Institut-Orsay proton therapy center (ICPO).
    Dendale R; Lumbroso-Le Rouic L; Noel G; Feuvret L; Levy C; Delacroix S; Meyer A; Nauraye C; Mazal A; Mammar H; Garcia P; D'Hermies F; Frau E; Plancher C; Asselain B; Schlienger P; Mazeron JJ; Desjardins L
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):780-7. PubMed ID: 16647221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetics of uveal melanoma: a 7-year clinical experience.
    Damato B; Duke C; Coupland SE; Hiscott P; Smith PA; Campbell I; Douglas A; Howard P
    Ophthalmology; 2007 Oct; 114(10):1925-31. PubMed ID: 17719643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.